Sun Pharmaceutical Industries shares in focus as company allots NCDs on private placement basis
Why did Sun Pharmaceutical Industries Ltd shares jump today?
Sun Pharmaceutical Industries Ltd shares edged higher on Monday, trading at ₹1752.0 as of 02:07 PM, reflecting a modest gain of 0.52%. The uptick came after the company announced that it has completed the allotment of Non-Convertible Debentures (NCDs) on a private placement basis. The announcement was made on 26 October 2026, under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The rated, listed, unsecured, redeemable NCDs carry an aggregate face value of ₹7,816 crore, which is a significant fundraising move for the pharmaceutical giant.
The NCD allotment is divided into two series — Series A with an aggregate face value of ₹2,003 crore and Series B with an aggregate face value of ₹5,813 crore. The base issue size of ₹7,000 crore was fully subscribed, and the company also exercised its greenshoe option to the extent of ₹816 crore out of the total greenshoe option available of up to ₹3,000 crore. This indicates strong investor appetite for the company's debt instrument, as the base issue was fully taken up and additional demand allowed the company to raise more than the base amount.
The successful allotment of these NCDs signals robust confidence from institutional investors in Sun Pharma's financial health and credit profile. The funds raised through this private placement are expected to strengthen the company's balance sheet and provide flexibility for future investments, debt management, or expansion activities. With Sun Pharma being one of India's largest pharmaceutical companies, this debt raise further reinforces its standing in the market and has been viewed positively by investors, contributing to the marginal rise in its share price during the trading session.
What does Sun Pharmaceutical Industries Ltd do?
Sun Pharmaceutical Industries Limited is an Indian company headquartered at SUN HOUSE, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai 400063, India, with corporate identification number L24230GJ1993PLC019050. The company is listed on the National Stock Exchange of India Limited under the code SUNPHARMA and on BSE Limited under the code 524715, and it maintains investor and secretarial communications through its website at www.sunpharma.com and the email address secretarial@sunpharma.com.
On 26 October 2026, the company completed the allotment, on a private placement basis, of rated, listed, unsecured, redeemable, non-convertible debentures (NCDs) aggregating to INR 7,816 crore, comprising Series A NCDs with an aggregate face value of INR 2,003 crore and Series B NCDs with an aggregate face value of INR 5,813 crore. The base issue size of INR 7,000 crore was fully subscribed, and based on the bids received and accepted, the company exercised the greenshoe option to the extent of INR 816 crore, with the issuance disclosed to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Sun Pharmaceutical Industries Ltd Financials
In CroresSun Pharmaceutical Industries Ltd reported revenue of ₹14,559.75 Crores in the quarter ending March 2026, which increased to ₹15,183.55 Crores in the quarter ending June 2026, reflecting a sequential growth of approximately 4.3%. Profit also showed a positive trend, rising from ₹2,714.03 Crores in March 2026 to ₹2,894.79 Crores in June 2026, a sequential increase of about 6.7%. The fact that profit grew at a faster rate than revenue indicates an improvement in profitability, suggesting better cost management or operating efficiency during the June 2026 quarter. Overall, the company demonstrated healthy sequential growth across both top-line and bottom-line metrics.
Sun Pharmaceutical Industries Ltd Shareholding Pattern
Promoter holding stands at 52.68% of the total share capital. Foreign Institutional Investors (FIIs) hold 14.36% stake in the company, while Domestic Institutional Investors (DIIs) hold 22.27%. Public shareholders hold the remaining 10.7% stake in Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd FAQs
Q: Why did Sun shares jump 0.52% today?
Allotment of Non-convertible securities (NCDs) on Private Placement basis. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Sun Pharmaceutical Industries Ltd?
As per the latest data, promoters hold 52.68% stake in Sun Pharmaceutical Industries Ltd, while FII holding stands at 14.36%. Domestic institutional investors hold 22.27%, and public shareholders account for 10.7% of the equity.
Q: What is the current stock price of Sun Pharmaceutical Industries Ltd?
Sun Pharmaceutical Industries Ltd shares are currently trading at ₹1752.0, recording a gain of 0.52% from the previous close.
Q: What is the market capitalization of Sun Pharmaceutical Industries Ltd?
The company currently has a market capitalization of ₹420363.49 crore, reflecting its valuation in the Indian equity market.